Inside the research
Astrana Health, Inc.
ASTH Research profile · latest available data
Price overview
$36.37
▲ +1.93 (+5.6%)
| 52w hi | $49.81 |
|---|---|
| 52w lo | $18.16 |
| Vol | 336.60K |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.09
| Short | -0.19 |
|---|---|
| Medium | +0.20 |
| Long | +0.44 |
computed 2026-09-27
Key fundamentals
Astrana Health, Inc.
Healthcare · Medical Care Facilities
| Market cap | $1.80B |
|---|---|
| Enterprise value | $2.21B |
| Trailing P/E | 44.35x |
| Forward P/E | 10.00x |
| EV / EBITDA | 12.62x |
| P / S (ttm) | 0.47x |
| Profit margin | 1.1% |
| Return on equity | 6.9% |
| Revenue growth | +48.5% |
| Earnings growth | +110.5% |
| Debt / equity | 163.62 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.33 | |
| Sector | +0.08 | |
| Technical | -0.10 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.
Risk Metrics
| Beta vs SPX | 0.58 |
|---|---|
| Corr SPX | 0.14 |
| Annual vol | 65.7% |
| Annual ret | -0.6% |
| Sharpe | -0.01 |
| Max DD | -71.0% |
Window: 504 trading days (504 obs)
Analyst Coverage
| Mean PT | $42.44 |
|---|---|
| High / Low | $50.00 / $35.00 |
| Median | $43.00 |
| Analysts | 9 |
| Strong Buy | 1 | |
|---|---|---|
| Buy | 8 | |
| Hold | 2 | |
| Sell | 0 | |
| Strong Sell | 0 |
Recent rating actions
| 2026-05-08 | Needham | → Buy |
| 2026-05-08 | BTIG | → Buy |
| 2026-04-15 | Baird | → Outperform |
| 2026-03-13 | Truist Securities | → Buy |
| 2026-02-02 | BTIG | → Buy |
| 2025-12-12 | Needham | → Buy |
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-06 | Earnings Release, Reg FD Disclosure… | read |
| 2026-07-13 | Reg FD Disclosure, Exhibits | read |
| 2026-07-01 | Officer / Director Change | read |
| 2026-06-10 | Officer / Director Change, Shareholder Vote… | read |
| 2026-05-12 | Officer / Director Change | read |
| 2026-05-12 | Reg FD Disclosure, Exhibits | read |
| 2026-05-07 | Earnings Release, Reg FD Disclosure… | read |
| 2026-03-30 | Other Material Event, Exhibits | read |
| 2026-03-04 | Reg FD Disclosure, Exhibits | read |
| 2026-03-02 | Earnings Release, Reg FD Disclosure… | read |
| 2026-01-12 | Reg FD Disclosure, Exhibits | read |
| 2025-11-06 | Earnings Release, Reg FD Disclosure… | read |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 8 |
| Top-5 share | 97.4% |
| HHI | 4,088 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| State Street Corp | $80.70M | 1.74M |
| Fidelity / FMR LLC | $31.83M | 685.92K |
| Capital Research / Capital World | $8.91M | 191.96K |
| Millennium Management | $8.84M | 190.50K |
| Renaissance Technologies | $3.46M | 74.65K |
| Citadel Advisors | $2.69M | 58.07K |
| AQR Capital Management | $818.12K | 17.63K |
| T. Rowe Price Group | $2.88K | 62.16K |
As of 2026-06-30
SEC Filings
The Long Run
FY 2011–2025 · 14 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $3.18B | +67.5% | |
| Gross profit | $1.41M | +55.6% | |
| Operating income | $78.53M | +199.8% | |
| Net income | $60.72M | +11.3% | |
| Cash from ops | $114.60M | +113.6% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $34.46 | $36.41 | $34.11 | $36.37 | 336.60K |
| Sep 24 | $34.32 | $34.54 | $33.54 | $34.44 | 391.50K |
| Sep 23 | $33.08 | $34.46 | $32.22 | $34.34 | 405.10K |
| Sep 22 | $34.11 | $35.52 | $33.40 | $35.11 | 409.50K |
| Sep 21 | $34.40 | $34.44 | $32.22 | $33.55 | 603.50K |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →